Business Wire (Wed, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Business Wire (May 3, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 11, 2013)
-
Incyte's Jakafi Is Likely A $1 Billion DrugOhad Hammer • Wed, Feb 27 -
Business Wire (Feb 20, 2013)
-
-
Business Wire (Jan 24, 2013)
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
Incyte's Jakafi Is Likely A $1 Billion DrugOhad Hammer • Wed, Feb 27
-
-
-
-
-
-
-
Incyte: Myelofibrosis Drug Looks PromisingOhad Hammer • Mon, Dec 27, 2010
-
Odds Increase for Approval of Incyte's Myelofibrosis DrugProhost Biotech • Wed, Sep 29, 2010
-
Incyte Extends Losses, Increases RevenueZacks Investment Research • Sun, Feb 21, 2010
-
Cohen's SAC Capital Boosts Passive Stake in Incyte to 6.4%Lon Juricic • Fri, Aug 8, 2008
-
-
-
-
-
-
-
-
-
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short CoveringKapitall • Fri, Nov 30, 2012 -
-
-
-
-
-
-
-
-
4 Mid-Cap Healthcare Stocks With Strong Projected Growth And Analyst BackingZetaKap • Wed, Aug 22, 2012 -
-
-
Incyte's CEO Discusses Q3 2012 Results - Earnings Call TranscriptThu, Nov 1, 2012
-
Incyte's CEO Discusses Q2 2012 Results - Earnings Call TranscriptThu, Aug 2, 2012
-
Incyte's CEO Discusses Q1 2012 Results - Earnings Call TranscriptThu, Apr 26, 2012
-
Incyte CEO Discusses Q3 2011 - Earnings Call TranscriptTue, Nov 1, 2011
-
Incyte Corp. CEO Discusses Q2 2011 Results - Earnings Call TranscriptThu, Jul 28, 2011
-
Incyte CEO Discusses Q4 2010 Results - Earnings Call TranscriptThu, Feb 10, 2011
-
Business Wire (Wed, 8:00AM)
-
Business Wire (May 3, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 11, 2013)
-
Business Wire (Feb 20, 2013)
-
Business Wire (Jan 24, 2013)
-
Business Wire (Dec 19, 2012)
-
Business Wire (Dec 10, 2012)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 19, 2012)
-
Business Wire (Nov 5, 2012)
-
Business Wire (Oct 22, 2012)
-
Business Wire (Oct 9, 2012)
-
Business Wire (Sep 19, 2012)
INCY vs. ETF Alternatives
Company Description
Incyte is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. We have a broad pipeline with programs focused primarily in the areas of oncology and inflammation. We focus our efforts on clinical programs that we... More
